GOLDMAN SACHS GROUP INC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 70 filers reported holding HUMACYTE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$388,313
+82.1%
132,530
+77.8%
0.00%
Q2 2023$213,210
+9.7%
74,549
+18.6%
0.00%
Q1 2023$194,309
+65.6%
62,883
+13.1%
0.00%
Q4 2022$117,303
-49.9%
55,594
-22.5%
0.00%
Q3 2022$234,000
+69.6%
71,758
+67.3%
0.00%
Q2 2022$138,000
-79.6%
42,903
-55.3%
0.00%
Q1 2022$678,000
+20.4%
95,966
+23.5%
0.00%
Q4 2021$563,00077,6850.00%
Other shareholders
HUMACYTE INC shareholders Q1 2023
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders